Lancet 392 , 21802193 (2018)
Introduction Neurobehavioral and metabolic effects of GLP-1 RAs How GLP-1 RAs affect appetite Changes in cravings, mood, and behavior How GLP-1 drugs may reshape addiction pathways Clinical and public health implications Conclusions References Further reading The widely used obesity and diabetes GLP-1 drugs may do far more than reduce weight
As glucose levels fall and your insulin needs drop, GLP-1 agonists stop stimulating the production of the hormone
Still, in the process, you do get more delay in gastric emptying, which is what leads to the drug interaction between tirzepatide and oral hormonal contraceptives. The FDA recommends that people using the drug also use backup birth control when starting injections and every time they increase their dosage
All statistical analyses were performed using Prism 10.0.2 by GraphPad Software, Inc
Without intentional protein prioritization, you risk losing muscle mass along with fat